Silence Therapeutics plc: Silence Therapeutics to Buyback si

Deal gives Silence exclusive worldwide rights to two siRNA complement assets Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company

Related Keywords

Hansoh Pharma , Craig Tooman , Exchange Commission , Astrazeneca , Corporate Communications , Mallinckrodt Pharmaceuticals , Nasdaq , Securities Litigation Reform Act , Admission Document , Annual Report , Silence , Herapeutics , Uyback , Dirna , Complement , Assets ,